A detailed history of D.A. Davidson & Co. transactions in Novartis Ag stock. As of the latest transaction made, D.A. Davidson & Co. holds 487,140 shares of NVS stock, worth $48 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
487,140
Previous 492,082 1.0%
Holding current value
$48 Million
Previous $52.4 Million 6.95%
% of portfolio
0.47%
Previous 0.47%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $524,494 - $597,438
-4,942 Reduced 1.0%
487,140 $56 Million
Q2 2024

Jul 31, 2024

SELL
$92.57 - $107.37 $112,935 - $130,991
-1,220 Reduced 0.25%
492,082 $52.4 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $593,055 - $675,225
6,225 Added 1.28%
493,302 $47.7 Million
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $931,927 - $1.03 Million
-10,100 Reduced 2.03%
487,077 $49.2 Million
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $63,374 - $70,331
669 Added 0.13%
497,177 $50.6 Million
Q2 2023

Aug 10, 2023

SELL
$92.52 - $104.91 $1.93 Million - $2.19 Million
-20,901 Reduced 4.04%
496,508 $50.1 Million
Q1 2023

Apr 25, 2023

BUY
$80.03 - $92.81 $2.38 Million - $2.76 Million
29,725 Added 6.1%
517,409 $47.6 Million
Q4 2022

Feb 03, 2023

BUY
$75.55 - $92.52 $288,525 - $353,333
3,819 Added 0.79%
487,684 $44.2 Million
Q3 2022

Nov 07, 2022

BUY
$74.61 - $87.26 $749,308 - $876,352
10,043 Added 2.12%
483,865 $36.8 Million
Q2 2022

Jul 28, 2022

BUY
$80.52 - $93.75 $341,163 - $397,218
4,237 Added 0.9%
473,822 $40.1 Million
Q1 2022

May 12, 2022

BUY
$80.11 - $90.62 $1.61 Million - $1.82 Million
20,123 Added 4.48%
469,585 $41.2 Million
Q4 2021

Jan 31, 2022

BUY
$79.7 - $88.13 $1.25 Million - $1.38 Million
15,638 Added 3.6%
449,462 $39.3 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $282,549 - $328,708
3,455 Added 0.8%
433,824 $35.5 Million
Q2 2021

Aug 10, 2021

BUY
$85.24 - $94.15 $1.53 Million - $1.68 Million
17,893 Added 4.34%
430,369 $39.3 Million
Q1 2021

May 07, 2021

BUY
$83.5 - $98.47 $5.02 Million - $5.92 Million
60,072 Added 17.05%
412,476 $35.3 Million
Q4 2020

Feb 10, 2021

BUY
$78.07 - $94.43 $988,131 - $1.2 Million
12,657 Added 3.73%
352,404 $33.3 Million
Q3 2020

Nov 02, 2020

BUY
$82.14 - $91.0 $1.04 Million - $1.15 Million
12,656 Added 3.87%
339,747 $29.5 Million
Q2 2020

Aug 10, 2020

SELL
$80.93 - $91.1 $4.39 Million - $4.95 Million
-54,306 Reduced 14.24%
327,091 $28.6 Million
Q1 2020

May 05, 2020

BUY
$70.67 - $99.01 $1.8 Million - $2.53 Million
25,513 Added 7.17%
381,397 $31.4 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $1.36 Million - $1.54 Million
16,123 Added 4.75%
355,884 $33.7 Million
Q3 2019

Nov 05, 2019

BUY
$85.54 - $94.26 $914,165 - $1.01 Million
10,687 Added 3.25%
339,761 $29.5 Million
Q2 2019

Aug 13, 2019

SELL
$75.4 - $92.8 $11.5 Million - $14.2 Million
-152,771 Reduced 31.71%
329,074 $30 Million
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $651,743 - $745,455
8,653 Added 1.83%
481,845 $46.2 Million
Q4 2018

Jan 29, 2019

BUY
$73.66 - $82.02 $859,391 - $956,927
11,667 Added 2.53%
473,192 $40.6 Million
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $1.44 Million - $1.66 Million
21,475 Added 4.88%
461,525 $39.8 Million
Q2 2018

Aug 02, 2018

BUY
$64.91 - $73.36 $644,815 - $728,758
9,934 Added 2.31%
440,050 $33.2 Million
Q1 2018

May 04, 2018

BUY
$70.39 - $84.15 $462,039 - $552,360
6,564 Added 1.55%
430,116 $34.8 Million
Q4 2017

Feb 08, 2018

SELL
$72.33 - $77.64 $6.7 Million - $7.19 Million
-92,577 Reduced 17.94%
423,552 $35.6 Million
Q3 2017

Nov 08, 2017

BUY
$74.14 - $77.27 $250,370 - $260,940
3,377 Added 0.66%
516,129 $44.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
512,752
512,752 $0

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.